JP2025516796A - ヒトサーコウイルスの同定 - Google Patents

ヒトサーコウイルスの同定 Download PDF

Info

Publication number
JP2025516796A
JP2025516796A JP2024568408A JP2024568408A JP2025516796A JP 2025516796 A JP2025516796 A JP 2025516796A JP 2024568408 A JP2024568408 A JP 2024568408A JP 2024568408 A JP2024568408 A JP 2024568408A JP 2025516796 A JP2025516796 A JP 2025516796A
Authority
JP
Japan
Prior art keywords
seq
hcirv
protein
nucleic acid
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024568408A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516796A5 (https=
Inventor
フィリップ、ペロ
マルク、エロワ
ベアトリス、ルニョー
ニコラ、ダ、ローシャ
アンヌ、ジャメ
ジャック、フルゴー
マリアンヌ、ルリュエ－ビル
アニエス、フェローニ
オリビエ、ロートラリー
クレール、ルゾー
デルフィーヌ、クレチアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Universite Paris Cite
Institut Pasteur
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Universite Paris Cite
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, Universite Paris Cite, Institut Pasteur filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of JP2025516796A publication Critical patent/JP2025516796A/ja
Publication of JP2025516796A5 publication Critical patent/JP2025516796A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2024568408A 2022-05-18 2023-05-17 ヒトサーコウイルスの同定 Pending JP2025516796A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263343205P 2022-05-18 2022-05-18
US63/343,205 2022-05-18
US202263373343P 2022-08-24 2022-08-24
US63/373,343 2022-08-24
PCT/IB2023/000264 WO2023223092A1 (en) 2022-05-18 2023-05-17 Identification of a human circovirus

Publications (2)

Publication Number Publication Date
JP2025516796A true JP2025516796A (ja) 2025-05-30
JP2025516796A5 JP2025516796A5 (https=) 2026-04-20

Family

ID=86904168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024568408A Pending JP2025516796A (ja) 2022-05-18 2023-05-17 ヒトサーコウイルスの同定

Country Status (5)

Country Link
EP (1) EP4526478A1 (https=)
JP (1) JP2025516796A (https=)
KR (1) KR20250075537A (https=)
CN (1) CN119585444A (https=)
WO (1) WO2023223092A1 (https=)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32011A (en) 1861-04-09 Coffee-pot
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
CN110527717B (zh) * 2018-01-31 2023-08-18 完美（广东）日用品有限公司 用于2型糖尿病的生物标志物及其用途
US10982187B2 (en) * 2019-03-26 2021-04-20 Genus Plc Bos taurus variety ‘HO840003150607238’ and methods of use thereof
CN109943664A (zh) * 2019-03-27 2019-06-28 天津大学 一种猪圆环病毒3快速检测方法及其试剂盒

Also Published As

Publication number Publication date
WO2023223092A1 (en) 2023-11-23
KR20250075537A (ko) 2025-05-28
EP4526478A1 (en) 2025-03-26
CN119585444A (zh) 2025-03-07

Similar Documents

Publication Publication Date Title
Pankuweit et al. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens
Pérot et al. Circovirus hepatitis infection in heart-lung transplant patient, France
JP2016005470A (ja) マイコバクテリアによる感染の診断方法およびそのための試薬
WO2012163263A1 (en) Reagents and methods for prrsv detection
JPH06506823A (ja) ノーワーク及び関連のウィルスを検出し同定するための方法と試薬
Sharawi et al. Isolation, Serological and Real time PCR diagnosis of Peste Des Petites Ruminants virus in naturally exposed Arabian Gazelle in Saudi Arabia.
Bradley-Dunlop et al. Development of monoclonal antibodies fordetection of necrotizing hepatopancreatitisin penaeid shrimp
JP2025516796A (ja) ヒトサーコウイルスの同定
Goossens et al. Early detection of cytomegalovirus in renal transplant recipients: comparison of PCR, NASBA, pp65 antigenemia, and viral culture
CN114163521B (zh) 一种鉴别猪瘟病毒2.1亚型强毒株及其抗体的单克隆抗体
Buchbinder et al. Mixed lung infection by Legionella pneumophila and Legionella gormanii detected by fluorescent in situ hybridization
EP2413960B1 (en) Diagnostic test for avian nephritis virus
RU2728342C1 (ru) Набор олигонуклеотидных праймеров и зондов и способ выявления пестивируса Н крупного рогатого скота
KR101025595B1 (ko) 노로바이러스 검출용 항체, 및 이를 이용한 노로바이러스검출방법
KR101080071B1 (ko) 재조합 ｎ 단백질에 대한 단클론 항체를 이용한 리프트계곡열 경합적 효소결합면역측정법
Xu et al. A Combined Method Based on the FIPV N Monoclonal Antibody Immunofluorescence Assay and RT‐nPCR Method for the Rapid Diagnosis of FIP‐Suspected Ascites
AU2012221740A1 (en) Exogenous internal positive control
JPH11511027A (ja) Ｇｂ型肝炎ウィルス遺伝子型の検出
JP2007145775A (ja) ノロウイルスｇｉの高感度検出方法
JPWO2002040509A1 (ja) ノーウォークウイルスに対する抗体及びこの抗体を用いたウイルスの検出方法
CN114934043A (zh) 检测犬立克次氏体和犬埃立克体的引物探针组合物、试剂盒及其制备方法
RU2548799C1 (ru) Олигонуклеотидные праймеры, днк-зонд и способ для идентификации вируса инфекционной анемии лошадей методом пцр или от-пцр в режиме реального времени
KR102900608B1 (ko) 바토넬라균 검출용 프라이머 세트
RU2823531C1 (ru) Способ диагностики вирусного репродуктивно-респираторного синдрома свиней с помощью флуоресцентной гибридизации in-situ (fish)
Wasissa et al. Feline coronavirus detection in clinically suspected feline infectious peritonitis cats

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260410

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260410